MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 91 filers reported holding MYOVANT SCIENCES LTD in Q1 2022. The put-call ratio across all filers is 1.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $31,735,073 | -55.4% | 1,177,158 | -85.1% | 0.02% | -56.6% |
| Q3 2022 | $71,080,009 | +4.9% | 7,907,682 | +45.1% | 0.05% | +12.8% |
| Q2 2022 | $67,735,000 | -8.7% | 5,449,107 | -2.2% | 0.05% | +30.6% |
| Q1 2022 | $74,228,000 | -13.8% | 5,572,904 | +0.8% | 0.04% | 0.0% |
| Q4 2021 | $86,064,000 | -32.5% | 5,527,464 | -2.7% | 0.04% | -35.7% |
| Q3 2021 | $127,436,000 | +3.2% | 5,679,050 | +4.8% | 0.06% | +5.7% |
| Q2 2021 | $123,427,000 | +14.5% | 5,421,017 | +3.5% | 0.05% | +8.2% |
| Q1 2021 | $107,826,000 | -23.4% | 5,239,282 | +2.8% | 0.05% | -24.6% |
| Q4 2020 | $140,815,000 | +152.9% | 5,098,315 | +28.6% | 0.06% | +124.1% |
| Q3 2020 | $55,686,000 | -33.0% | 3,963,483 | -1.7% | 0.03% | -38.3% |
| Q2 2020 | $83,123,000 | +133.6% | 4,031,200 | -14.5% | 0.05% | +95.8% |
| Q1 2020 | $35,587,000 | -51.4% | 4,713,489 | -0.1% | 0.02% | -36.8% |
| Q4 2019 | $73,249,000 | +204.4% | 4,719,627 | +2.0% | 0.04% | +192.3% |
| Q3 2019 | $24,064,000 | -38.9% | 4,627,784 | +6.4% | 0.01% | -38.1% |
| Q2 2019 | $39,371,000 | -34.2% | 4,350,335 | +73.6% | 0.02% | -36.4% |
| Q1 2019 | $59,828,000 | +42.2% | 2,506,392 | -2.2% | 0.03% | +22.2% |
| Q4 2018 | $42,076,000 | -37.2% | 2,564,066 | +1.5% | 0.03% | -25.0% |
| Q3 2018 | $67,044,000 | +161.0% | 2,525,193 | +124.8% | 0.04% | +140.0% |
| Q2 2018 | $25,692,000 | – | 1,123,397 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |